These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8299855)

  • 21. Lipo-PGE1, a new lipid-encapsulated preparation of prostaglandin E1: placebo-and prostaglandin E1-controlled multicenter trials in patients with diabetic neuropathy and leg ulcers.
    Toyota T; Hirata Y; Ikeda Y; Matsuoka K; Sakuma A; Mizushima Y
    Prostaglandins; 1993 Nov; 46(5):453-68. PubMed ID: 8278621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate improvement of diabetic mononeuropathy after intravenous administration of prostaglandin E1.
    Shimizu H; Shimomura Y; Inukai T; Takahashi M; Uehara Y; Kobayashi I; Kobayashi S
    Jpn J Med; 1990; 29(2):222-5. PubMed ID: 2232371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of direct renin inhibitor monotherapy on proteinuria in overt diabetic nephropathy.
    Silaratana S; Sumransurp S; Duangchana S; Tasanarong A
    J Med Assoc Thai; 2012 Jan; 95 Suppl 1():S18-23. PubMed ID: 23964439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention.
    Pedraza-Chaverrí J; Cruz C; Ibarra-Rubio ME; Chávez MT; Calleja C; Tapia E; del Carmen Uribe M; Romero L; Peña JC
    Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin receptor blocker and N-acetyl cysteine for reduction of proteinuria in patients with type 2 diabetes mellitus.
    Rasi Hashemi S; Noshad H; Tabrizi A; Mobasseri M; Tayebi Khosroshahi H; Heydarnejad M; Khalaj MR; Aghamohammadzadeh N
    Iran J Kidney Dis; 2012 Jan; 6(1):39-43. PubMed ID: 22218118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of prostaglandin E1 on renin and aldosterone in hypertensive patients.
    Yoshimura M; Takahashi H; Takashina R; Kajita Y; Miyazaki T; Hachiya T; Ijichi H; Ochi Y
    Endocrinol Jpn; 1979 Aug; 26(4):481-6. PubMed ID: 499089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of rofecoxib on the glomerular filtration rate, proteinuria and the renin-angiotensin-aldosterone system in elderly subjects with chronic renal impairment.
    Horackova M; Schück O; Komers R; Charvat J; Teplan V; Kvapil M
    Int J Clin Pharmacol Ther; 2005 Sep; 43(9):413-9. PubMed ID: 16163893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silymarin for diabetic nephropathy: the challenges of botanical product research.
    Meyers CM; Briggs JP
    Am J Kidney Dis; 2012 Dec; 60(6):887-9. PubMed ID: 23141996
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma renin and aldosterone in adult-onset diabetics with persistent proteinuria.
    Sugiyama H; Uchimura I; Odakura T; Maezawa H
    Jpn J Med; 1981 Jul; 20(3):194-201. PubMed ID: 7040751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renin-angiotensin-aldosterone system in mild diabetic nephropathy.
    Tomita K; Matsuda O; Ideura T; Shiigai T; Takeuchi J
    Nephron; 1982; 31(4):361-7. PubMed ID: 6757774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
    Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
    Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.
    Park JH; Jang HR; Lee JH; Lee JE; Huh W; Lee KB; Kwon YJ; Do JY; Kim HY; Kim YG
    Nephrology (Carlton); 2015 Apr; 20(4):279-85. PubMed ID: 25522682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
    Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E
    J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dual blockade of the renin-angiotensin system on the progression of type 2 diabetic nephropathy: a randomized trial.
    Fernandez Juarez G; Luño J; Barrio V; de Vinuesa SG; Praga M; Goicoechea M; Cachofeiro V; Nieto J; Fernández Vega F; Tato A; Gutierrez E;
    Am J Kidney Dis; 2013 Feb; 61(2):211-8. PubMed ID: 22939518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of prostaglandin E1 on arterial ketone body ratio during and after hepatectomy].
    Nakayama M; Kanaya N; Fujita S; Kawana S; Namiki A
    Masui; 1995 Sep; 44(9):1224-7. PubMed ID: 8523654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of the renin-angiotensin-aldosterone system to atrial natriuretic peptide and the natriuresis of volume expansion in diabetics with and without proteinuria.
    O'Hare JP; Anderson JV; Millar ND; Bloom SR; Corrall RJ
    Postgrad Med J; 1988; 64 Suppl 3():35-8; discussion 48-9. PubMed ID: 2977818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy.
    Schjoedt KJ; Lajer M; Andersen S; Tarnow L; Rossing P; Parving HH
    Scand J Clin Lab Invest; 2006; 66(3):173-80. PubMed ID: 16714246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of nitroglycerin and prostaglandin E1 administration during cardiac surgery].
    Misawa Y; Hasegawa T; Kato M; Sakata K; Yamaguchi T; Fukuda H
    Kyobu Geka; 1991 Apr; 44(4):294-8. PubMed ID: 1903820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
    Hirsch S
    Int J Clin Pract; 2010 Sep; 64(10):1337-40. PubMed ID: 20716140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.